Risks and Benefits of Therapies for Apnoea in Premature Infants, Drug Safety, vol.132, issue.5, pp.363-79, 2000. ,
DOI : 10.1016/S0022-3476(86)80786-7
Intermittent Hypoxic Episodes in Preterm Infants: Do They Matter?, Neonatology, vol.100, pp.303-313, 2011. ,
Apnea Is Associated with Neurodevelopmental Impairment in Very Low Birth Weight Infants, Journal of Perinatology, vol.107, issue.4, pp.763-771, 2004. ,
DOI : 10.1542/peds.107.4.638
INVESTIGATION OF DOXAPRAM AS A POSTANESTHETIC RESPIRATORY STIMULANT, Anesthesia & Analgesia, vol.43, issue.6, pp.628-668, 1964. ,
DOI : 10.1213/00000539-196411000-00006
The Search for a Pharmacologic Ventilator, Acta Anaesthesiologica Scandinavica, vol.10, pp.63-71, 1966. ,
DOI : 10.1111/j.1399-6576.1966.tb00993.x
Pharmacokinetics of Doxapram in Idiopathic Apnea of
Prematurity, Developmental Pharmacology and Therapeutics, vol.11, issue.2, pp.65-72, 1988. ,
DOI : 10.1159/000457668
Doxapram Dosage Regimen in Apnea of Prematurity Based on
Pharmacokinetic Data, Developmental Pharmacology and Therapeutics, vol.11, issue.5, pp.253-260, 1988. ,
DOI : 10.1159/000457699
Enteral absorption of doxapram in premature newborns, Pediatr Res, vol.78, pp.289-92, 1998. ,
Aminophyllin versus doxapram in idiopathic apnea of prematurity: a double blind controlled study, Pediatrics, vol.75, pp.709-722, 1985. ,
Doxapram for the Initial Treatment of Idiopathic Apnea of Prematurity, Neonatology, vol.61, issue.4, pp.209-222, 1992. ,
DOI : 10.1159/000243744
Low-dose doxapram therapy for idiopathic apnea of prematurity, Pediatrics International, vol.11, issue.2, pp.124-131, 2001. ,
DOI : 10.1159/000457668
Low-Dose Doxapram Therapy in Premature Infants and Its CSF and Serum Concentrations, Acta Paediatrica, vol.80, issue.8-9, pp.786-91, 1991. ,
DOI : 10.1021/jm00326a004
Severe Side Effects and Drug Plasma Concentrations in Preterm Infants Treated With Doxapram, Therapeutic Drug Monitoring, vol.21, issue.5, pp.547-52, 1999. ,
DOI : 10.1097/00007691-199910000-00011
The Ventilatory Effects of Doxapram in Normal Man, Clinical Science, vol.65, issue.1, pp.65-74, 1983. ,
DOI : 10.1042/cs0650065
A new centrally acting agent (AHR-619) with marked respiratory stimulating, pressor, and " awakening " effects, Fed Proc, vol.6, pp.142-147, 1962. ,
ELECTROPHYSIOLOGIC ANALYSIS OF THE SITE OF ACTION OF DOXAPRAM HYDROCHLORIDE, Survey of Anesthesiology, vol.11, issue.1, pp.360-368, 1966. ,
DOI : 10.1097/00132586-196702000-00020
POSSIBLE SITES OF ACTION OF THE RESPIRATORY STIMULANT EFFECT OF DOXAPRAM HYDROCHLORIDE, Survey of Anesthesiology, vol.9, issue.2, pp.260-264, 1964. ,
DOI : 10.1097/00132586-196504000-00016
Selective respiratory stimulating action of doxapram compared to pentylenetetrazaol, J Pharmacol Exp Ther, vol.189, pp.1-11, 1974. ,
Caffeine Therapy for Apnea of Prematurity, New England Journal of Medicine, vol.354, issue.20, pp.2112-2133, 2006. ,
DOI : 10.1056/NEJMoa054065
Dose response relationship of the doxapram in the therapy for refractory idiopathic apnea of prematurity, Pediatrics, vol.80, pp.22-29, 1987. ,
Randomized, controlled, blinded trial of doxapram for extubation of the very low birthweight infant, Acta Paediatrica, vol.145, issue.2, pp.191-195, 1998. ,
DOI : 10.1016/S0022-3476(86)80786-7
Doxapram versus methylxanthine for apnea in preterm infants, Cochrane Database of Systematic Reviews, vol.59, issue.4, p.75, 2000. ,
DOI : 10.1002/14651858.CD000075
Enqu??te sur l'utilisation du doxapram dans les unit??s de n??onatologie en France, Archives de P??diatrie, vol.12, issue.2, pp.151-156, 2005. ,
DOI : 10.1016/j.arcped.2004.10.024
FATAL BENZYL ALCOHOL POISONING IN A NEONATAL INTENSIVE CARE UNIT, The Lancet, vol.319, issue.8283, p.1250, 1982. ,
DOI : 10.1016/S0140-6736(82)92377-7
Avery's Neonatalology: Pathophysiology and Management of the Newborn, pp.288-92, 2005. ,
Electroencephalographic Evidence of Arousal in Dogs from Halothane after Doxapram, Physostigmine, or Naloxone, Anesthesiology, vol.55, issue.4, pp.392-397, 1981. ,
DOI : 10.1097/00000542-198110000-00010
The effects of doxapram, diazepam, phenobarbital and pentylenetetrazol on suprathreshold and threshold stimulations in amygdaloid kindled rats, Neuropharmacology, vol.22, issue.2, pp.245-253, 1983. ,
DOI : 10.1016/0028-3908(83)90016-3
Side effects of doxapram infusion, European Journal of Intensive Care Medicine, vol.8, issue.2, pp.87-95, 1976. ,
DOI : 10.1007/BF01886121
USE OF DOXAPRAM TO INCREASE RESPIRATIONS WITHOUT A CONCOMITANT INCREASE IN INTRACRANIAL PRESSURE, Critical Care Medicine, vol.15, issue.11, pp.1072-1075, 1987. ,
DOI : 10.1097/00003246-198711000-00019
The effect of doxapram on brain imaging in patients with panic disorder, European Neuropsychopharmacology, vol.17, issue.10, pp.672-86, 2007. ,
DOI : 10.1016/j.euroneuro.2007.04.002
Hemodynamic Responses to Doxapram in Normovolemic and Hypovolemic Dogs, Anesthesia & Analgesia, vol.50, issue.5, pp.705-715, 1971. ,
DOI : 10.1213/00000539-197150050-00003
Second-degree atrioventricular heart block after doxapram administration, The Journal of Pediatrics, vol.133, issue.1, pp.149-50, 1998. ,
DOI : 10.1016/S0022-3476(98)70197-0
QT interval lengthening in premature infants treated with doxapram, Clinical Pharmacology & Therapeutics, vol.70, issue.6, pp.540-545, 2001. ,
DOI : 10.1016/S0009-9236(01)95877-1
Doxapram and hypokalaemia in very preterm infants: Table??1, Archives of Disease in Childhood - Fetal and Neonatal Edition, vol.11, issue.(4), pp.416-424, 2013. ,
DOI : 10.1007/s004670050260
Isolated mental developmental delay in very low birth weight infants: Association with prolonged doxapram therapy for apnea, The Journal of Pediatrics, vol.139, issue.6, pp.832-839, 2001. ,
DOI : 10.1067/mpd.2001.119592
Doxapram and developmental delay at 12 months in children born extremely preterm, Acta Paediatrica, vol.46, issue.11, pp.1680-1681, 2005. ,
DOI : 10.1080/08035250500254449
Methylxanthine treatment for apnea in preterm infants, Cochrane Database Syst Rev, vol.135, issue.4, p.140, 2001. ,
DOI : 10.1002/14651858.CD000074.pub2
Steer PA Caffeine versus theophylline for apnea in preterm infants, Cochrane Database Syst Rev, vol.1, p.273, 2010. ,
Long-Term Effects of Caffeine Therapy for Apnea of Prematurity, New England Journal of Medicine, vol.357, issue.19, pp.1893-902, 2007. ,
DOI : 10.1056/NEJMoa073679
Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity ,
Low-dose doxapram for treatment of apnoea following early weaning in very low birthweight infants : a randomized, double-blind study, Acta Paediatr, vol.87, pp.1180-1184, 1998. ,
Traitement des apn??es du pr??matur??, Archives de P??diatrie, vol.5, issue.5, pp.546-52, 1998. ,
DOI : 10.1016/S0929-693X(99)80321-2
Respiratory and non respiratory effects of doxapram in congenital central hypoventilation syndrome, Am Rev Respir Dis, vol.119, pp.263-269, 1979. ,
Effects of doxapram on cerebral blood flow velocity in preterm infants, Neuropediatrics, vol.35, pp.126-135, 2004. ,
Brain Hemodynamic Effects of Doxapram in Preterm Infants, Neonatology, vol.187, issue.2, pp.69-74, 2006. ,
DOI : 10.1203/00006450-199112000-00016
Doxapram accentuates white matter injury in neonatal rats following bilateral carotid artery occlusion, Neuroscience Letters, vol.281, issue.2-3 ,
DOI : 10.1016/S0304-3940(00)00859-4
Brunet-Lézine révisé, échelle de développement psychomoteur de la petite enfance, Manuel BLR-C. Editions et applications psychologiques, 1997. ,
The apparent breastfeeding paradox in very preterm infants: relationship between breast feeding, early weight gain and neurodevelopment based on results from two cohorts, EPIPAGE and LIFT, BMJ Open, vol.2, issue.2, pp.834-1136, 2012. ,
DOI : 10.1136/bmjopen-2012-000834
Doxapram treatment for apnea in preterm infants ,
Doxapram use for apnea of prematurity in neonatal intensive care, Int J Pediatr, vol.2013, pp.251-256, 2013. ,
Postnatal steroids in extremely low birth weight infants: betamethasone or hydrocortisone?, Acta Paediatrica, vol.14, issue.7, pp.689-94, 2013. ,
DOI : 10.1007/s004670050771
Nachsorge des fr??hgeborenen Kindes, Therapeutische Umschau, vol.70, issue.11, pp.648-52, 2013. ,
DOI : 10.1024/0040-5930/a000460